• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖作为造影剂肾病的危险因素。

Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy.

机构信息

Department of Vascular Surgery, 9898University Hospitals of North Midlands NHS Trust, UK.

Department of Renal Medicine, Royal Free & University College Medical School and Royal Free Hospital, London, UK.

出版信息

Angiology. 2021 Mar;72(3):274-278. doi: 10.1177/0003319720969536. Epub 2020 Nov 24.

DOI:10.1177/0003319720969536
PMID:33228378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7859667/
Abstract

Contrast-induced nephropathy (CIN) is common. Risk factors include preexisting renal impairment, diabetes, elderly age, and dehydration. In a single-centre prospective study, we investigated which factors are implicated for CIN in patients with peripheral arterial disease due for angiography. Serum creatinine was measured before, 1, 2, and 7 days post-angiography. We also considered the chronic kidney disease stage of the patients at admission and 48 hours post-contrast. All patients received 500 mL normal saline pre- and post-angiography and a low-osmolality contrast medium. 6 of 94 patients developed CIN: 1 required dialysis and 1 died partly due to renal failure. Only 2 factors were associated with CIN: body mass index (BMI; = .019) and kidney function ( = .001); 4 of 6 patients with CIN were obese (BMI ≥30) and only 2 were nonobese ( = .0092). Diabetes, contrast volume, and age were not significant risk factors. Our results confirm renal impairment raises the risk of CIN. To our knowledge, we report for the first time that obesity may be a risk factor for CIN. Pending confirmatory studies and given the rising prevalence of obesity, this finding could help identify at-risk patients and hence reduce the burden of CIN.

摘要

对比剂肾病(CIN)很常见。危险因素包括:原有肾脏损害、糖尿病、老年和脱水。在一项单中心前瞻性研究中,我们研究了因血管造影而患有外周动脉疾病的患者中哪些因素与 CIN 相关。在血管造影前、后第 1、2 和 7 天测量血清肌酐。我们还考虑了患者入院时和造影后 48 小时的慢性肾脏病分期。所有患者在血管造影前后均接受 500mL 生理盐水,并使用低渗透压造影剂。94 例患者中有 6 例发生 CIN:1 例需要透析,1 例部分因肾衰竭死亡。只有 2 个因素与 CIN 相关:体重指数(BMI; =.019)和肾功能( =.001);6 例 CIN 患者中有 4 例肥胖(BMI≥30),仅有 2 例非肥胖( =.0092)。糖尿病、造影剂用量和年龄不是显著的危险因素。我们的结果证实肾功能损害会增加 CIN 的风险。据我们所知,我们首次报告肥胖可能是 CIN 的一个危险因素。在确认性研究进行之前,鉴于肥胖的患病率不断上升,这一发现可以帮助识别高危患者,从而降低 CIN 的负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f50/7859667/187dc84087d6/10.1177_0003319720969536-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f50/7859667/187dc84087d6/10.1177_0003319720969536-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f50/7859667/187dc84087d6/10.1177_0003319720969536-fig1.jpg

相似文献

1
Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy.肥胖作为造影剂肾病的危险因素。
Angiology. 2021 Mar;72(3):274-278. doi: 10.1177/0003319720969536. Epub 2020 Nov 24.
2
Contrast-Induced Nephropathy: A Fact or Fiction in Lower Limb Revascularization?
Ann Vasc Surg. 2017 Oct;44:277-281. doi: 10.1016/j.avsg.2017.03.193. Epub 2017 May 4.
3
Risk factors for contrast-induced nephropathy after coronary angiography.冠状动脉造影术后对比剂肾病的危险因素。
Saudi J Kidney Dis Transpl. 2017 Mar-Apr;28(2):318-324. doi: 10.4103/1319-2442.202758.
4
Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.外周血管介入治疗后对比剂肾病:长期肾脏结局和肾功能进行性损害的危险因素。
J Vasc Surg. 2019 Mar;69(3):913-920. doi: 10.1016/j.jvs.2018.06.196. Epub 2018 Oct 3.
5
CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.CHA2DS2-VASC评分作为慢性完全闭塞患者经皮冠状动脉介入治疗中对比剂肾病的术前预测指标:单中心经验
BMC Cardiovasc Disord. 2019 Mar 29;19(1):74. doi: 10.1186/s12872-019-1060-0.
6
The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography.非急诊冠状动脉造影术后具有临床意义的对比剂诱导的肾病的发生率。
Catheter Cardiovasc Interv. 2008 Jun 1;71(7):879-85. doi: 10.1002/ccd.21565.
7
Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.抗坏血酸预防慢性肾功能损害患者冠状动脉造影后对比剂肾病:一项随机对照试验
Ther Apher Dial. 2013 Aug;17(4):384-90. doi: 10.1111/1744-9987.12083.
8
High White Blood Cell Count Is a Risk Factor for Contrast-Induced Nephropathy following Mechanical Thrombectomy for Acute Ischemic Stroke.高白细胞计数是急性缺血性卒中机械取栓术后造影剂诱导的肾病的危险因素。
Cerebrovasc Dis Extra. 2020;10(2):59-65. doi: 10.1159/000507918. Epub 2020 Jul 1.
9
The influence of contrast media on kidney function in patients with stable coronary artery disease.造影剂对稳定型冠状动脉疾病患者肾功能的影响。
Scand Cardiovasc J. 2014 Aug;48(4):234-40. doi: 10.3109/14017431.2014.934713. Epub 2014 Jul 18.
10
Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.碘化造影剂剂量:一种用于对急性冠状动脉综合征患者对比剂肾病风险进行分层的新的简单算法。
Catheter Cardiovasc Interv. 2013 Nov 15;82(6):888-97. doi: 10.1002/ccd.24847. Epub 2013 Jul 17.

引用本文的文献

1
The Impact of Insulin Resistance on the Development of Post-PCI Contrast-Induced Nephropathy in Non-Diabetic STEMI.胰岛素抵抗对非糖尿病性ST段抬高型心肌梗死患者PCI术后造影剂肾病发生的影响
Acta Cardiol Sin. 2025 Jan;41(1):130-137. doi: 10.6515/ACS.202501_41(1).20241018B.
2
Predictors for Irreversibility of Contrast-Induced Acute Kidney Injury in Patients with Obesity After Contrast-Enhanced Computed Tomography Coronary Angiography.肥胖患者在对比增强计算机断层扫描冠状动脉造影后发生对比剂诱导的急性肾损伤不可逆性的预测因素
Adv Ther. 2025 Jan;42(1):293-309. doi: 10.1007/s12325-024-03036-z. Epub 2024 Nov 11.
3
Perirenal Fat Thickness Is Associated With Contrast-Induced Nephropathy in Type 2 Diabetic Patients Undergoing Coronary Catheterization.

本文引用的文献

1
Global vascular guidelines on the management of chronic limb-threatening ischemia.全球血管指南:慢性肢体威胁性缺血的管理。
J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28.
2
Metabolic Syndrome Increases Mortality Risk in Dialysis Patients: A Systematic Review and Meta-Analysis.代谢综合征增加透析患者的死亡风险:一项系统评价和荟萃分析。
Int J Endocrinol Metab. 2018 Feb 7;16(2):e61201. doi: 10.5812/ijem.61201. eCollection 2018 Apr.
3
Do Statins Induce or Protect from Acute Kidney Injury and Chronic Kidney Disease: An Update Review in 2018.
肾周脂肪厚度与行冠状动脉造影检查的 2 型糖尿病患者造影剂肾病相关。
J Diabetes Res. 2024 Aug 22;2024:4905669. doi: 10.1155/2024/4905669. eCollection 2024.
4
The relationship between H2FPEF score and contrast induced nephropathy in patients with ST elevation myocardial infarction.ST段抬高型心肌梗死患者中H2FPEF评分与造影剂肾病的关系。
J Cardiovasc Thorac Res. 2022;14(4):240-245. doi: 10.34172/jcvtr.2022.30537. Epub 2022 Dec 24.
他汀类药物会诱发还是预防急性肾损伤和慢性肾脏病:2018年最新综述
J Transl Int Med. 2018 Mar 28;6(1):21-25. doi: 10.2478/jtim-2018-0005. eCollection 2018 Mar.
4
Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.对比剂后急性肾损伤。第 2 部分:风险分层、水化和其他预防措施的作用、服用二甲双胍的患者和慢性透析患者:更新 ESUR 对比剂安全委员会指南的建议。
Eur Radiol. 2018 Jul;28(7):2856-2869. doi: 10.1007/s00330-017-5247-4. Epub 2018 Feb 7.
5
Obesity and kidney disease: Hidden consequences of the epidemic.肥胖与肾脏疾病:这一流行病的潜在后果
Indian J Nephrol. 2017 Mar-Apr;27(2):85-92. doi: 10.4103/ijn.IJN_61_17.
6
Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.预防性水化以保护高危对比剂肾病(AMACING)患者的肾功能免受血管内碘造影剂影响:一项前瞻性、随机、3 期、对照、开放标签、非劣效性试验。
Lancet. 2017 Apr 1;389(10076):1312-1322. doi: 10.1016/S0140-6736(17)30057-0. Epub 2017 Feb 21.
7
Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography.冠状动脉造影检查的肾功能正常患者中对比剂诱导的肾病
J Renal Inj Prev. 2016 Feb 26;5(1):21-4. doi: 10.15171/jrip.2016.05. eCollection 2016.
8
Contrast-Induced Nephropathy.造影剂肾病
Circulation. 2015 Nov 17;132(20):1931-6. doi: 10.1161/CIRCULATIONAHA.115.014672.
9
Statins in the prevention of contrast-induced nephropathy.他汀类药物用于预防造影剂肾病
Curr Treat Options Cardiovasc Med. 2015 Apr;17(4):375. doi: 10.1007/s11936-015-0375-0.
10
Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention.水化在接受直接经皮冠状动脉介入治疗患者的对比剂肾病中的作用。
Am J Cardiol. 2015 May 1;115(9):1174-8. doi: 10.1016/j.amjcard.2015.02.004. Epub 2015 Feb 12.